Observational studyRevista da Associacao Medica Brasileira (1992)2023
Programmed cell death protein 1 is a marker for neoadjuvant chemotherapy response in triple-negative breast cancer.
Maria de Fátima Dias Gaui et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.